Becton Dickinson and Co
Change company Symbol lookup
Select an option...
BDX Becton Dickinson and Co
GGN GAMCO Global Gold, Natural Resources & Income Trust
GUT Gabelli Utility Trust
CHD Church & Dwight Co Inc
CHY Calamos Convertible & High Income Fund
CHW Calamos Global Dynamic Income Fund
CCVIX Calamos Convertible Fund Class A
ETY Eaton Vance Tax-Managed Diversified Equity Income Fund
ETB Eaton Vance Tax-Managed Buy-Write Income Fund
NEE Nextera Energy Inc

Health Care : Health Care Equipment & Supplies | Large Cap Blend
Company profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.

Closing Price
Day's Change
-6.00 (-2.43%)
B/A Size
Day's High
Day's Low
(Above Average)

10-day average volume:

UPDATE: U.S. stocks sweep to fresh records despite dour January jobs report

4:19 pm ET February 5, 2021 (MarketWatch)

By Mark DeCambre

U.S. economy adds 49,000 jobs in January, unemployment rate falls to 6.3% from 6.7%

U.S. stock indexes notched their best weekly gain since the November elections Friday, even though the latest update on employment showed a disappointing jobs gain in January, suggesting that recovery in the labor market is stalling.

On Thursday (, the S&P 500 notched its sixth record close of 2021, while the Nasdaq registered its seventh record of the year so far, and the Dow finished just 0.4% off its all-time closing high. The small-capitalization focused Russell 2000 climbed 1.8%, setting a record.

For the week, the Russell gained 7.6%, the Nasdaq added 6%, the S&P 500 index advanced 4.7%, and the Dow ended 3.9% higher.

The U.S. Labor Department's employment report ( 49,000 jobs were added in January, while the unemployment rate fell to 6.3% from 6.7%.

The results affirm the view that the recovery in the jobs market is stalling out amid the COVID-19 pandemic that has slammed the U.S. economy. Some 10 million jobs that vanished in the early stages of the pandemic still haven't returned.

"By looking at the US [nonfarm payrolls] data, it is clear that massive strength that we have seen previously in a lot of areas in no longer there," wrote Naeem Aslam, chief market analyst at AvaTrade. "This means that the US lawmakers can push really hard for the next second stimulus package," he wrote after the labor data was released.

The January report follows a reading from December that showed that 140,000 jobs were lost, marking the first monthly decline in employment figures in about eight months when the COVID-19 pandemic ( walloped the country.

The January report comes as many states reimposed business restrictions at the end of last year to combat the pandemic and restaurants and hotels had to lay off workers, some for the second or third time.

The state of employment is likely to be even worse than the labor report for last month reflects, economists say. Several million people who dropped out of the labor force, bringing the unemployment rate lower, did so because they couldn't find work and thus aren't counted in the main unemployment rate.

Still, investors appeared upbeat on the basis of healthy earnings from American corporations in the second-busiest week of fourth quarter reporting season results, along with prospects for Congress passing President Joe Biden's $1.9 trillion coronavirus relief package, using a special reconciliation procedure.

The Senate early Friday approved ( a budget resolution, 51-to-50, that would allow for a fast tracking of the $1.9 trillion coronavirus relief plan.

One benefit of the softer employment data is that it could enhance the prospects for further fiscal spending under Biden.

"The biggest risk with the nonfarm payroll report was a strong rebound in hiring that could diminish the prospects of future fiscal stimulus," wrote Edward Moya, senior market analyst at Oanda, in a research note.

He notes that the slowness of the current recovery remains a key concern, as well as a sluggish bounceback that would have lingering impacts on parts of the economy.

"Economic scarring is happening as the number of long-term unemployed continues to stay at around the 4 million level," Moya wrote.

See: Biden says he could deliver $1.9 trillion aid package without Republican support (

Fears of a market correction that took hold last week, inspired by a Reddit-led group of individual investors, has given way to fresh gains for stocks. The rally for the major benchmarks now puts them on track for their best weekly gains in about three months, FactSet data show.

"US markets extended their rebound for the fourth day in a row yesterday, as the recent fallout from last week's Reddit inspired sell-off faded further," wrote Mark Hewson, chief market analyst at CMC Markets, in a daily research note.

"Improvements in US economic data, along with the prospect of further fiscal stimulus, have helped underpin this week's recovery."

Meanwhile, Treasury Secretary Janet Yellen said regulators would ensure investor protection, ( a months long social-media campaign by individual investors to drive up the value of heavily shorted stocks like GameStop Inc. (GME).

Popular trading app Robinhood Markets has removed the last of its trading limits on shares of GameStop and AMC Entertainment Holdings (AMC), among others. Market volatility associated with the reaction to the retail trading frenzy has significantly died down.

On the public-health front, Johnson & Johnson (JNJ) applied for on an emergency use authorization of its single-shot COVID vaccine (, which could result in Americans getting shots as early as March.

COVID-19 hospitalizations continued to fall, to 88,668 on Thursday, the lowest total since Nov. 24, according to the COVID Tracking Project ( However, the number of deaths in the U.S. resulting from the coronavirus that causes COVID-19 spiked above 5,000 for the first time on Thursday, snapping a declining trend.

In other economic reports, the U.S. international trade deficit fell in December (, but the nation's trade gap still climbed in 2020 to the highest level in 12 years due to the coronavirus pandemic. The trade gap slid 3.5% to $66.6 billion in December from $69 billion in November, the government said Friday (

See also:The rotation is for real, January fund flows confirm (

-Mark DeCambre; 415-439-6400;


(END) Dow Jones Newswires

February 05, 2021 16:19 ET (21:19 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.